602306-75-2

Upstream product

• 1192-30-9 tetrahydrofurfuryl bromide 
• 106-53-6 para-bromobenzenethiol 
• 821-09-0 n-Pent-4-enyl alcohol 
• 34176-08-4 sodium 4-bromobenzenesulfinate 
• 34583-63-6 rac-(tetrahydrofuran-2-yl)methyl 4-methylbenzenesulfonate 
• 97-99-4 Tetrahydrofurfuryl alcohol 

Downstream Products

• 602306-67-2 1-(tetrahydrofur-2-ylmethylsulphonyl)-4-bromobenzene 

Relevant academic research and scientific papers

SSAO INHIBITORS AND USE THEREOF

Provided are a compound of formula (I') or (I), a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of SSAO, a pharmaceutical composition comprising a compound of formula (I') or (I), and a method of treating or preventing a disease in which SSAO plays a role.

Copper-Catalyzed Oxysulfenylation of Enolates with Sodium Sulfinates: A Strategy to Construct Sulfenylated Cyclic Ethers

A new copper-catalyzed oxysulfenylation reaction of enolates with sodium sulfinates has been disclosed. A series of sulfenylated heterocycles including four- and seven-membered cyclic ether were obtained in mild to good yields. This reaction is proposed to go through a radical process, and the sulfur radical (RS?) may be a reactive species.

DERIVATIVES OF 4- (IMIDAZOL-5-YL)-2-(4-SULFOANILINO) PYRIMIDINE WITH CDK INHIBITORY ACTIVITY

Compounds of the formula (I): wherein R1, R2, R3, R4, R5 and p are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man.